- Research works
- 65 ▲ 67% vs 2013–17
- Citations
- 1.2k 18.8 per fractional work
- Top-10% rate
- 13.7% record average 16.5%
- Open access
- 16% world 28%
Not ranked overall: Arzneimittelkommission der deutschen Ärzteschaft is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 19.4×. Every wedge is a field page.
Which keywords describe research at Arzneimittelkommission der deutschen Ärzteschaft?
By fractional works in all years, weighted toward what it does more of than the world: Clinical Trials, Adverse Drug Reactions, Medication Adherence, Drug Development, Off-Label Drug Use, Pediatric Pharmacokinetics, Pharmaceutical Industry and Quality of Life.
- Publication Bias
- Cognitive Function
- Guideline Development
- Health Surveys
- Healthcare Utilization
- Healthcare Law
- Signal Detection
- Patient Rights
- Genetics
- Treatment Guidelines
- Informed Consent
- Clinical Guidelines
- Biosimilars
- Medical Ethics
- Drug Development Costs
- Health Utility Measures
- Pharmaceutical Industry
- Pediatric Pharmacokinetics
- Drug Development
- Adverse Drug Reactions
- Clinical Trials
- Medication Adherence
- Off-Label Drug Use
- Quality of Life
- Cost-effectiveness Analysis
- Inflammation
- Generic Drugs
- Monoclonal Antibodies
- Immunogenicity
- Chemotherapy
- Public Health
- Depression
- End-of-Life Care
- Pharmacovigilance
- Chronic Diseases
- Reproductive Medicine
- Germany
- Quality Assessment
- Practice Recommendations
- Neuroimaging
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Clinical Trials10▲ 25×9 topics
- Adverse Drug Reactions8▲ 190×2 topics
- Medication Adherence7▲ 174×2 topics
- Drug Development6▲ 69×2 topics
- Off-Label Drug Use6▲ 257×1 topic
- Pediatric Pharmacokinetics6▲ 257×1 topic
- Quality of Life5▲ 5.8×7 topics
- Pharmaceutical Industry5▲ 191×2 topics
- Cost-effectiveness Analysis4▲ 79×1 topic
- Health Utility Measures4▲ 79×1 topic
- Inflammation4▲ 2.6×14 topics
- Drug Development Costs4▲ 225×1 topic
- Generic Drugs4▲ 225×1 topic
- Medical Ethics3▲ 30×4 topics
- Monoclonal Antibodies3▲ 34×2 topics
- Biosimilars3▲ 288×1 topic
- Immunogenicity3▲ 84×1 topic
- Clinical Guidelines3▲ 13×4 topics
- Chemotherapy2▲ 5.1×8 topics
- Informed Consent2▲ 41×2 topics
- Public Health2▲ 2.6×6 topics
- Treatment Guidelines2▲ 17×3 topics
- Depression2▲ 4.3×9 topics
- Genetics2▲ 4.2×7 topics
- End-of-Life Care2▲ 21×2 topics
- Patient Rights2▲ 31×2 topics
- Pharmacovigilance2▲ 233×1 topic
- Signal Detection2▲ 233×1 topic
- Chronic Diseases2▲ 9.8×2 topics
- Healthcare Law2▲ 113×1 topic
- Reproductive Medicine2▲ 113×1 topic
- Healthcare Utilization2▲ 34×2 topics
- Germany2▲ 80×1 topic
- Health Surveys2▲ 80×1 topic
- Quality Assessment2▲ 13×2 topics
- Guideline Development2▲ 80×1 topic
- Practice Recommendations2▲ 80×1 topic
- Cognitive Function1▲ 11×3 topics
- Neuroimaging1▲ 7.6×3 topics
- Publication Bias1▲ 41×2 topics
Which research topics does Arzneimittelkommission der deutschen Ärzteschaft publish most on?
By volume in 2022–2025: Pharmaceutical Economics and Policy, Pharmaceutical studies and practices, Chronic Lymphocytic Leukemia Research and Biosimilars and Bioanalytical Methods.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pharmaceutical Economics and Policy Economics and Econometrics 1 works
- 2 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 1 works
- 3 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 4 Biosimilars and Bioanalytical Methods Immunology 0 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 6 Immunodeficiency and Autoimmune Disorders Immunology 0 works
- 7 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 8 Immune Cell Function and Interaction Immunology 0 works
- 9 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 10 Treatment of Major Depression Pharmacology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Arzneimittelkommission der deutschen Ärzteschaft's research output changed?
Output in 2018–2022 was 67% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Berlin
- Bundeswehr
- Staatliche Museen zu Berlin
- German Center for Integration and Migration Research
- Quadriga Hochschule Berlin
- Forum transregionale Studien e.V.
- Institute for Educational Quality Improvement
- Berlin Institute for the Foundations of Learning and Data
- Sachverständigenrat für Umweltfragen
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.